Abstract

In our previous study, two known piperidine alkaloids (+)-spectaline (1) and iso-6-spectaline (2) were isolated from the leaves of Senna spectabilis and showed no toxic effect on L6 cells. In view of the potential use of piperidine alkaloids in S. spectabilis for the treatment of sleeping sickness, further investigation on the cell death actions of the parasite after treatment with compound 1 and 2 suggested that the treated parasites died by a process of autophagy based on the characteristic morphological alterations observed in intracellular T. b. rhodesiense. In search for apoptosis, interestingly, trypanosomes treated with high concentration of compound 1 and 2 after 72 h significantly induced an early apoptosis-like programmed cell death (PCD) such as phosphatidylserine (PS) exposure, loss of mitochondrial membrane potential and caspases activation. No DNA laddering discriminated late apoptosis event. Taken together, these findings demonstrated the potential of compound 1 and 2 as a natural chemotherapeutic capable of inducing a possible cross-talk between autophagy and apoptosis in T. b. rhodesiense.

Highlights

  • Human African Trypanosomiasis (HAT) known as “sleeping sickness” is caused by two protozoan parasites, Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense

  • Trypanosomes treated with IC90 of compound 1 and 2 after 72 h exhibited an effect that significantly induced an early apoptosis-like programmed cell death (PCD), which included phosphatidylserine (PS) exposure, loss of mitochondrial membrane potential, and caspases activation. These findings demonstrated the potential of compound 1 and 2 as a natural chemotherapeutic. capable of inducing a possible cross-talk between autophagy and apoptosis in T. b. rhodesiense

  • In view of the potential use of piperidine alkaloids in S. spectabilis for the treatment of sleeping sickness, further investigation into the cell death actions of the parasite after treatment with compound 1 and 2 suggested that the treated parasites died by a process of autophagy based on the characteristic morphological alterations observed in intracellular T. b. rhodesiense

Read more

Summary

Introduction

Human African Trypanosomiasis (HAT) known as “sleeping sickness” is caused by two protozoan parasites, Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense. Rhodesiense without toxic effect on mammalian L6 cells It can be considered a potential candidate for HAT early drug discovery. Trypanosomes treated with IC90 of compound 1 and 2 after 72 h exhibited an effect that significantly induced an early apoptosis-like PCD, which included phosphatidylserine (PS) exposure, loss of mitochondrial membrane potential, and caspases activation. Taken together, these findings demonstrated the potential of compound 1 and 2 as a natural chemotherapeutic. Quantitative analysis of FITC fluorescence was done to show the PS exposure

DNA Fragmentation Analysis
Determination of Caspase-Like Protease Activity
Autophagy Assay
Measurement of Mitochondrial Membrane Potential
Conclusions

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.